LYVE1 (lymphatic vessel endothelial hyaluronan receptor-1) has been identified as a biomarker of lymphangiogenesis and lymph node metastasis in multiple cancers with poor prognoses (49–51). This evidence concerns the gene LYVE1 and metastatic malignant neoplasm in the lymph nodes.